← back to search
Bolan Linghu
AstraZeneca (United Kingdom) · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Bioinformatics and Genomic Networks, and Computational Drug Discovery Methods.
h-index
18
citations
2,158
works
36
NIH funding
—
primary concept
Medicine
email
blinghu@gmail.com
Recent publications
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Nature
2021
cited by
589
position: middle
doi
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
Blood Advances
2019
cited by
183
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Richard R. Furman
· Cornell University
1
papers (2019–2019)
Jennifer A. Woyach
· Ohio University
1
papers (2019–2019)
Jennifer R. Brown
· Harvard University
1
papers (2019–2019)
Melanie M. Frigault
· Vifor Pharma (United States)
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Raquel Izumi
· Vifor Pharma (United States)
1
papers (2019–2019)
Deborah M. Stephens
· University of North Carolina at Chapel Hill
1
papers (2019–2019)
Prista Charuworn
· Amgen (United States)
1
papers (2019–2019)
John M. Pagel
· Eppendorf (Germany)
1
papers (2019–2019)
Peter Hillmen
· Leeds Teaching Hospitals NHS Trust
1
papers (2019–2019)
Farrukh T. Awan
· Northeast Ohio Medical University
1
papers (2019–2019)
Ahmed Hamdy
· Ain Shams University
1
papers (2019–2019)
Anna Schuh
· Science Oxford
1
papers (2019–2019)
Min Hui Wang
· Ruijin Hospital
1
papers (2019–2019)
Priti Patel
· St. Vincent Hospital
1
papers (2019–2019)
John C. Byrd
· The University of Texas Southwestern Medical Center
1
papers (2019–2019)